octahydroimidazo[1,5-a]pyrazin-3-one hydrochloride
|
O628730-250mg
|
≥97% |
1376340-66-7 |
250mg
|
¥ 1509.9
|
期货,请咨询 |
阿拉丁 |
octahydroimidazo[1,5-a]pyrazin-3-one hydrochloride
|
O628730-1g
|
≥97% |
1376340-66-7 |
1g
|
¥ 3775.9
|
期货,请咨询 |
阿拉丁 |
octahydroimidazo[1,5-a]pyrazin-3-one hydrochloride
|
O628730-100mg
|
≥97% |
1376340-66-7 |
100mg
|
¥ 941.9
|
期货,请咨询 |
阿拉丁 |
(2R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-oxo-piperidine-2-carboxylic acid
|
O628716-5g
|
≥97% |
1375078-38-8 |
5g
|
¥ 6639.9
|
期货,请咨询 |
阿拉丁 |
(2R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-oxo-piperidine-2-carboxylic acid
|
O628716-1g
|
≥97% |
1375078-38-8 |
1g
|
¥ 1648.9
|
期货,请咨询 |
阿拉丁 |
(2R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-oxo-piperidine-2-carboxylic acid
|
O628716-10g
|
≥97% |
1375078-38-8 |
10g
|
¥ 13212.9
|
期货,请咨询 |
阿拉丁 |
7-oxaspiro[3.5]nonan-2-amine
|
O628703-500mg
|
≥97% |
1374658-89-5 |
500mg
|
¥ 4050.9
|
期货,请咨询 |
阿拉丁 |
7-oxaspiro[3.5]nonan-2-amine
|
O628703-250mg
|
≥97% |
1374658-89-5 |
250mg
|
¥ 2433.9
|
期货,请咨询 |
阿拉丁 |
7-oxaspiro[3.5]nonan-2-amine
|
O628703-1g
|
≥97% |
1374658-89-5 |
1g
|
¥ 7294.9
|
期货,请咨询 |
阿拉丁 |
7-oxaspiro[3.5]nonan-2-amine
|
O628703-100mg
|
≥97% |
1374658-89-5 |
100mg
|
¥ 1522.9
|
期货,请咨询 |
阿拉丁 |
O4-tert-butyl O3-methyl 1,4-oxazepane-3,4-dicarboxylate
|
O628692-5g
|
≥97% |
1374652-85-3 |
5g
|
¥ 25080.9
|
期货,请咨询 |
阿拉丁 |
O4-tert-butyl O3-methyl 1,4-oxazepane-3,4-dicarboxylate
|
O628692-500mg
|
≥97% |
1374652-85-3 |
500mg
|
¥ 3344.9
|
期货,请咨询 |
阿拉丁 |
O4-tert-butyl O3-methyl 1,4-oxazepane-3,4-dicarboxylate
|
O628692-250mg
|
≥97% |
1374652-85-3 |
250mg
|
¥ 2004.9
|
期货,请咨询 |
阿拉丁 |
O4-tert-butyl O3-methyl 1,4-oxazepane-3,4-dicarboxylate
|
O628692-1g
|
≥97% |
1374652-85-3 |
1g
|
¥ 5016.9
|
期货,请咨询 |
阿拉丁 |
O4-tert-butyl O3-methyl 1,4-oxazepane-3,4-dicarboxylate
|
O628692-100mg
|
≥97% |
1374652-85-3 |
100mg
|
¥ 1252.9
|
期货,请咨询 |
阿拉丁 |
1-[(tert-butoxy)carbonyl]-2-oxoazetidine-3-carboxylic acid
|
O628664-5g
|
≥97% |
1370018-27-1 |
5g
|
¥ 25608.9
|
期货,请咨询 |
阿拉丁 |
1-[(tert-butoxy)carbonyl]-2-oxoazetidine-3-carboxylic acid
|
O628664-500mg
|
≥97% |
1370018-27-1 |
500mg
|
¥ 3416.9
|
期货,请咨询 |
阿拉丁 |
1-[(tert-butoxy)carbonyl]-2-oxoazetidine-3-carboxylic acid
|
O628664-250mg
|
≥97% |
1370018-27-1 |
250mg
|
¥ 2050.9
|
期货,请咨询 |
阿拉丁 |
1-[(tert-butoxy)carbonyl]-2-oxoazetidine-3-carboxylic acid
|
O628664-1g
|
≥97% |
1370018-27-1 |
1g
|
¥ 5121.9
|
期货,请咨询 |
阿拉丁 |
1-[(tert-butoxy)carbonyl]-2-oxoazetidine-3-carboxylic acid
|
O628664-100mg
|
≥97% |
1370018-27-1 |
100mg
|
¥ 1278.9
|
期货,请咨询 |
阿拉丁 |
5-oxaspiro[3.5]nonan-8-ol
|
O628641-5g
|
≥97% |
1368181-23-0 |
5g
|
¥ 11518.9
|
期货,请咨询 |
阿拉丁 |
5-oxaspiro[3.5]nonan-8-ol
|
O628641-1g
|
≥97% |
1368181-23-0 |
1g
|
¥ 2875.9
|
期货,请咨询 |
阿拉丁 |
5-oxaspiro[3.5]nonan-8-ol
|
O628641-10g
|
≥97% |
1368181-23-0 |
10g
|
¥ 23036.9
|
期货,请咨询 |
阿拉丁 |
5-oxaspiro[3.5]nonan-8-one
|
O628635-5g
|
≥97% |
1367945-40-1 |
5g
|
¥ 11518.9
|
期货,请咨询 |
阿拉丁 |